HIV molecular immunology database
TQGYFPDWQNYTPGPGVRYPLTFGWCYKLVP
|
Nef(117-147) | human epitope |
QGYFPDWQNYTPGPGVRY
|
Nef(118-135) | C*16 human epitope |
QGYFPDWQNYTPGPGRF
|
Nef(118-135) | human epitope |
QGYFPDWQNYTPGPvRy
|
Nef(118-135) | subtype-specific susceptible form |
QGYFPDWQNYTPGPGIRY
|
Nef(118-135) | human epitope |
QGYFPDWQNYTPGPGIRY
|
Nef(118-135) | human epitope |
YFPDWQNYTPGPGIRYPLTFGWCYK
|
Nef(120-144) | A24 human epitope |
FPDWQNYTPGPGIRY
|
Nef(121-135) | A*02:01 human epitope |
FPDWQNYTPGPGIRY
|
Nef(121-135) | A24 human epitope |
FPDWQNYTPGPGIRY
|
Nef(121-135) | human epitope |
FPDWQNYTPGPGIRYPLT
|
Nef(121-138) | human epitope |
FPDWQNYTPGPGtRYPLT
|
Nef(121-138) | observed variant |
FPDWQNYTPGPGIRYPLT
|
Nef(121-138) | human epitope |
PDWQNYTPGPGVRYP
|
Nef(122-136) | human epitope |
PDWQNYTPGPGVRYPLTFGW
|
Nef(122-141) | B*35 human epitope |
PDWQNYTPGPGVRYPLTFGW
|
Nef(122-141) | human epitope |
QWQNYTPGPGVRYPL
|
Nef(123-137) | human epitope |
WQNYTPGPGIRYPLT
|
Nef(124-138) | human epitope |
WQNYTPGPGIRYPLT
|
Nef(124-138) | human epitope |
QNYTPGPGIRYPLTF
|
Nef(125-139) | A*02:01 human epitope |
QNYTPGPGVRYPLTF
|
Nef(125-139) | human epitope |
QNYTPGPGRFPLTFGWCF
|
Nef(125-143) | human epitope |
QNYTPGPGvRyPLTFGWCF
|
Nef(125-143) | subtype-specific susceptible form |
NYTPGPGVRY
|
Nef(126-135) | A24 human epitope |
NYTPGPGIRY
|
Nef(126-135) | A*24:02 human epitope |
NYTPGPGIRY
|
Nef(126-135) | A*24:02 human epitope |
NYTPGPGvRY
|
Nef(126-135) | observed variant |
cYTPGPGtRY
|
Nef(126-135) | observed variant |
NYTPGPGtRY
|
Nef(126-135) | observed variant |
NYTPGPGIRf
|
Nef(126-135) | observed variant |
NYTPGPGtRf
|
Nef(126-135) | observed variant |
cYTPGPGIRf
|
Nef(126-135) | observed variant |
gYTPGPGIRf
|
Nef(126-135) | observed variant |
cYTPGPGtRf
|
Nef(126-135) | observed variant |
gYTPGPGtRf
|
Nef(126-135) | observed variant |
NYTPGPGvRf
|
Nef(126-135) | observed variant |
NYTPGPGeRf
|
Nef(126-135) | observed variant |
NYTPGPGvRl
|
Nef(126-135) | observed variant |
NYTPGPGtRw
|
Nef(126-135) | observed variant |
NYTPGPGVRYPLT
|
Nef(126-138) | B7 human epitope |
NYTPGPGTRYPLTFG
|
Nef(126-140) | A24 human epitope |
NYTPGPGTRYPLTFG
|
Nef(126-140) | B35 human epitope |
NYTPGPGTRYPLTFG
|
Nef(126-140) | human epitope |
NYTPGPGVRYPLTFGWCF
|
Nef(126-143) | C*14 human epitope |
NYTPGPGIRYPLTFGWCF
|
Nef(126-143) | human epitope |
NYTPGPGIRYPLCFGWCF
|
Nef(126-143) | human epitope |
NYTPGPGIRYPLTFGWCF
|
Nef(126-143) | human epitope |
YTPGPGIRY
|
Nef(127-135) | A*23 human epitope |
YTPGPGIRY
|
Nef(127-135) | A*24 human epitope |
YTPGPGIRY
|
Nef(127-135) | B*35:02, B*35:03, B*53:01 human epitope |
YTPGPGIRY
|
Nef(127-135) | B*57 human epitope |
YTPGPGIRY
|
Nef(127-135) | B*57 human epitope |
YTPGPGIRY
|
Nef(127-135) | B57, B58 human epitope |
YTPGPGVRY
|
Nef(127-135) | B*58:01 human epitope |
YTPGPGIRY
|
Nef(127-135) | B*63 human epitope |
YTPGPGTRY
|
Nef(127-135) | human epitope |
YTPGPGIRY
|
Nef(127-135) | human epitope |
YTPGPGVRY
|
Nef(127-135) | human epitope |
YTPGPGVRYPLTFGW
|
Nef(127-141) | A24 human epitope |
YTPGPGVRYPLTFGW
|
Nef(127-141) | B35 human epitope |
YTPGPGVRYPLTFGW
|
Nef(127-141) | human epitope |
TPGPGVRY
|
Nef(128-135) | B*07:02 human epitope |
TPGPGVRY
|
Nef(128-135) | B7 supertype human epitope |
TPGPGVRYP
|
Nef(128-136) | B*07 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*07 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*07 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*07 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*07 human epitope |
TPGPGVKYPL
|
Nef(128-137) | B*07 human, transgenic mouse epitope |
TPGPGiKYPL
|
Nef(128-137) | susceptible form |
TPGPGVRYPL
|
Nef(128-137) | B*07 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*07 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*07 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*07, B*42 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*07:02 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*07:02 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*07:02 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*07:02 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*07:02 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*07:02 human epitope |
TPGPGIRYPL
|
Nef(128-137) | B*07:02 human epitope |
TPGPGvRYPL
|
Nef(128-137) | subtype-specific susceptible form |
TPGPGTRYPL
|
Nef(128-137) | B*07:02 human epitope |
TPGPGiRYPL
|
Nef(128-137) | non-susceptible form |
TPGPGvRYPL
|
Nef(128-137) | diminished response; escape documented in this paper; non-susceptible form; susceptible form |
TPGPGTRfPL
|
Nef(128-137) | diminished response; escape documented in this paper; non-susceptible form; susceptible form |
TPGPGIRYPL
|
Nef(128-137) | B*07:02 human epitope |
TPGPGvRYPL
|
Nef(128-137) | diminished response; escape documented in this paper; susceptible form |
TPGPGvRfPL
|
Nef(128-137) | diminished response; escape documented in this paper; susceptible form |
TPGPGvRwPL
|
Nef(128-137) | diminished response; escape documented in this paper; susceptible form |
TPGPGvRlPL
|
Nef(128-137) | diminished response; escape documented in this paper; susceptible form |
TPGPGtRfPL
|
Nef(128-137) | diminished response; escape documented in this paper; susceptible form |
TPGPGIRYPL
|
Nef(128-137) | B*07:02 human epitope |
TPGPGvRYPL
|
Nef(128-137) | susceptible form |
TPGPGVRYPL
|
Nef(128-137) | B*07:02, B*42:01 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*07:02, B7 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B35 human epitope |
TPGPGTRYPL
|
Nef(128-137) | B35 human epitope |
TPGPGvRYPL
|
Nef(128-137) | susceptible form |
TPGPGVRYPL
|
Nef(128-137) | B35 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*35:01 human epitope |
TsGPGVRYPL
|
Nef(128-137) | susceptible form |
TPGPGVRYPL
|
Nef(128-137) | B*35:02, B*35:03, B*53:01 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*42 human epitope |
TPGPGIRYPL
|
Nef(128-137) | B42 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*42:01 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*42:01 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*42:01 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*42:01 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*42:01 human epitope |
TsGPGVRYPL
|
Nef(128-137) | diminished HLA binding or increased off-rate; escape documented in this paper |
TqGPGVRYPL
|
Nef(128-137) | diminished HLA binding or increased off-rate; escape documented in this paper |
TPGPGVRYPL
|
Nef(128-137) | B*42:01 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*42:01, B*42:02 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*42:02 epitope |
TPGPGVRYPL
|
Nef(128-137) | B7 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B7 human epitope |
TPGPGiRYPL
|
Nef(128-137) | observed variant |
TPGPGVRYPL
|
Nef(128-137) | B7 human epitope |
TPGPGiRYPL
|
Nef(128-137) | observed variant |
TPGPGVRYPL
|
Nef(128-137) | B7 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B7 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B7 human epitope |
TPGPGiRYPL
|
Nef(128-137) | susceptible form |
TPGPGVRYPL
|
Nef(128-137) | B7 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B7 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B7 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B7 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B7 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B7 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B7 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B7 human, macaque epitope |
TPGPGVRYPL
|
Nef(128-137) | B7 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B7 human epitope |
TPGPGIRYPL
|
Nef(128-137) | B7 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B7 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B7 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*81:01, B7 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*81:01, B7 human epitope |
TPGPGVRYPL
|
Nef(128-137) | B7 supertype human epitope |
TPGPGVRYPL
|
Nef(128-137) | B*81:01 human epitope |
TPGPGVRYPL
|
Nef(128-137) | C*17 human epitope |
TPGPGVRYPL
|
Nef(128-137) | human epitope |
TPGPGIRYPL
|
Nef(128-137) | human epitope |
TPGPGvRYPL
|
Nef(128-137) | HLA association; susceptible form |
TPGPGVRYPL
|
Nef(128-137) | human epitope |
TPGPGTRYPL
|
Nef(128-137) | human epitope |
TPGPGIRFPL
|
Nef(128-137) | susceptible form |
TPGPGIRYPL
|
Nef(128-137) | susceptible form |
TPGPGIRYPV
|
Nef(128-137) | susceptible form |
TPGPGIRFPI
|
Nef(128-137) | susceptible form |
TSGPGTRFPL
|
Nef(128-137) | susceptible form |
IPGPG-RHPL
|
Nef(128-137) | observed variant |
TPGPGVRYPL
|
Nef(128-137) | observed variant |
TPGPGPRYPL
|
Nef(128-137) | susceptible form |
TPGPGTRFPL
|
Nef(128-137) | observed variant |
TPGPGPRFPL
|
Nef(128-137) | observed variant |
TPGPGIRYPM
|
Nef(128-137) | susceptible form |
TPGPGPRYPV
|
Nef(128-137) | susceptible form |
TPGPGPRYPM
|
Nef(128-137) | susceptible form |
TKGPGIRFPL
|
Nef(128-137) | susceptible form |
TPGPGPRYPM
|
Nef(128-137) | susceptible form |
TPGPGRFPL
|
Nef(128-137) | human epitope |
TPGPGvryPL
|
Nef(128-137) | observed variant |
TPGPGIRYPL
|
Nef(128-137) | human epitope |
TPGPGIRYPLTFGW
|
Nef(128-141) | human epitope |
TPGPGIRYPLTFGW
|
Nef(128-141) | human epitope |
TPGPGIRYPLTFGW
|
Nef(128-141) | human epitope |
PGPGTRFPLTFGWCF
|
Nef(129-143) | A23 human epitope |
PGPGTRFPLTFGWCF
|
Nef(129-143) | A24 human epitope |
PGPGTRFPLTFGWCF
|
Nef(129-143) | B35 human epitope |
PGPGIRYPLCFGWCF
|
Nef(129-143) | B35 human epitope |
PGPGIRYPLTFGWCF
|
Nef(129-143) | B57 human epitope |
PGPGIRYPLTFGWCF
|
Nef(129-143) | human epitope |
PGPGtRfPLTFGWCF
|
Nef(129-143) | observed variant |
PGPGIRYPLTFGWCF
|
Nef(129-143) | human epitope |
PGPGpRYPLTFGWCF
|
Nef(129-143) | non-susceptible form; susceptible form |
{PGPGT}RYPLTFGW{CFKLV}
|
Nef(129-146) | A*24 human epitope |
{PGPGT}RYPLTlGW{CFKLV}
|
Nef(129-146) | non-susceptible form; observed variant |
{PGPGT}RYPLmFGW{CFKLV}
|
Nef(129-146) | observed variant; susceptible form |
{PGPGi}RfPLTFGW{CFKLV}
|
Nef(129-146) | observed variant; susceptible form |
PGPGIRYPLTFGWCFKLV
|
Nef(129-146) | human epitope |
PGPGVRYPLTFGWCFKLV
|
Nef(129-146) | human epitope |
PGPGVRYPLTFGWCFKLVP
|
Nef(129-147) | human epitope |
GPGVRYPLTF
|
Nef(130-139) | B35 human epitope |
GPGVRYPLTF
|
Nef(130-139) | B35 human epitope |
GPGTRFPLTR
|
Nef(130-139) | B7 human epitope |
GPGIRYPLTFGWCF
|
Nef(130-143) | B*57 human epitope |
GPGVRYPLTFGWCY
|
Nef(130-143) | B*57 human epitope |
GPGVRYPLTFGWCY
|
Nef(130-143) | B*57 human epitope |
GPGVRYPLTFGWCY
|
Nef(130-143) | B57 human epitope |
GPGIRYPLTFGWCF
|
Nef(130-143) | B*58:01, B57 human epitope |
GPGVRYPLTFGWCYK
|
Nef(130-144) | human epitope |
GPGTRFPLTFGWCFKLV
|
Nef(130-146) | human epitope |
PGIRYPLTFGWCFKL
|
Nef(131-145) | A23 human epitope |
PGIRYPLTFGWCFKL
|
Nef(131-145) | A24 human epitope |
PGIRYPLTFGWCFKL
|
Nef(131-145) | B35 human epitope |
PGIRYPLTFGWCFKL
|
Nef(131-145) | human epitope |
PGIRYPLTFGWCFKL
|
Nef(131-145) | human epitope |
PGIRYPLTFGWCFKL
|
Nef(131-145) | human epitope |
PGIRYPLTFGWCFKL
|
Nef(131-145) | human epitope |
PGIRYPLTFGWCFKLVPVEP
|
Nef(131-150) | human epitope |
GIRYPLTFGWCFK
|
Nef(132-144) | human epitope |
GvRYPLTFGWCFK
|
Nef(132-144) | observed variant |
GIRYPLcFGWCFK
|
Nef(132-144) | observed variant |
GVRYPLTLGWCFKLV
|
Nef(132-146) | A24 human epitope |
GVRYPLTFGWCYKLVP
|
Nef(132-147) | A1, B8 human epitope |
GVRYPLTFGWCYKLVP
|
Nef(132-147) | B18 human epitope |
GVRYPLTFGWCYKLVP
|
Nef(132-147) | H-2d mouse epitope |
GIRYPLTFGWCFKLVP
|
Nef(132-147) | human epitope |
GVRYPLTFGWCYKLVPVEPD
|
Nef(132-151) | human epitope |
TRYPLTFGW
|
Nef(133-141) | A*03 human epitope |
TRYPLTFGW
|
Nef(133-141) | A*23 human epitope |
TRYPLTFGW
|
Nef(133-141) | A*24 human epitope |
TRYPLTFGW
|
Nef(133-141) | A*29 human epitope |
TRYPLTFGW
|
Nef(133-141) | A*33 human epitope |
TRYPLTFGW
|
Nef(133-141) | A33 human epitope |
TRYPLTFGW
|
Nef(133-141) | A*68:02 human epitope |
TRYPLTFGW
|
Nef(133-141) | B*18 human epitope |
VRYPLTFGW
|
Nef(133-141) | B27 human epitope |
VRYPLTFGW
|
Nef(133-141) | B*27:02 human epitope |
VRYPLTFGW
|
Nef(133-141) | B*27:05 human epitope |
TRYPLTFGW
|
Nef(133-141) | B*35:01, B*35:08 human epitope |
TRYPLTFGW
|
Nef(133-141) | B*35:02, B*35:03, B*53:01 human epitope |
TRYPLTFGW
|
Nef(133-141) | B*42:01 human epitope |
VRYPLTFGW
|
Nef(133-141) | C*04:01 human epitope |
IRYPKTFGW
|
Nef(133-141) | Mamu B*17 macaque epitope |
IRYPKTFGW
|
Nef(133-141) | Mamu B*17 macaque epitope |
VRYPLTFGW
|
Nef(133-141) | human epitope |
GRFPLTFGW
|
Nef(133-141) | human epitope |
tRyPLTFGW
|
Nef(133-141) | observed variant |
VRYPLTFGW
|
Nef(133-141) | human epitope |
IRYPLTFGWC
|
Nef(133-142) | B*27 human epitope |
TRYPLTFGWCYKLVP
|
Nef(133-147) | A24 human epitope |
TRYPLTFGWCYKLVP
|
Nef(133-147) | B35 human epitope |
IRYPLTFGWCFKLVP
|
Nef(133-147) | human epitope |
pRYPLTFGWCFKLVP
|
Nef(133-147) | non-susceptible form; susceptible form |
VRYPLTFGWCYKLVPV
|
Nef(133-148) | B57 human epitope |
RYPLTFGW
|
Nef(134-141) | A*23 human epitope |
RYPLTFGW
|
Nef(134-141) | A23, A24, B35, B53 human epitope |
RYPLTFGW
|
Nef(134-141) | A*23:01 human epitope |
RYPLTFGW
|
Nef(134-141) | A*23:01 human epitope |
RYPLTFGW
|
Nef(134-141) | A*23:01, A24 human epitope |
RYPLTFGW
|
Nef(134-141) | A*23:01, A*24:02 human epitope |
RYPLTFGW
|
Nef(134-141) | A*24 human epitope |
RYPLmFGW
|
Nef(134-141) | escape documented in this paper; observed variant |
RYPLTlGW
|
Nef(134-141) | escape documented in this paper; observed variant |
RfPLTFGW
|
Nef(134-141) | escape documented in this paper; observed variant |
RYPLTFGW
|
Nef(134-141) | A*24 human epitope |
RYPLTFGW
|
Nef(134-141) | A*24 human epitope |
RYPLTFGW
|
Nef(134-141) | A*24 human epitope |
RYPLTFGW
|
Nef(134-141) | A24 human epitope |
RYPLTFGW
|
Nef(134-141) | A24 human epitope |
RYPLTFGW
|
Nef(134-141) | A24 human epitope |
RYPLTFGW
|
Nef(134-141) | A24 human epitope |
RYPLTFGW
|
Nef(134-141) | A24 human epitope |
RYPLTFGW
|
Nef(134-141) | A*24:02 human epitope |
RfPLTFGW
|
Nef(134-141) | TCR related mutation |
RYPLTFGW
|
Nef(134-141) | A*24:02 human epitope |
RfPLTFGW
|
Nef(134-141) | diminished response; escape documented in this paper; non-susceptible form; susceptible form |
RYPLcFGW
|
Nef(134-141) | diminished response; escape documented in this paper; non-susceptible form; susceptible form |
RYPLTFGW
|
Nef(134-141) | A*24:02 human epitope |
RfPLTFGW
|
Nef(134-141) | altered KIR binding or increased/decreased off-rate |
RYPLTFGa
|
Nef(134-141) | susceptible form |
RYPLTFGW
|
Nef(134-141) | A*24:02 human epitope |
RYPLTFGW
|
Nef(134-141) | A*24:02 human epitope |
RYPLTFGW
|
Nef(134-141) | A*24:02 human epitope |
RYPLTFGW
|
Nef(134-141) | A*24:02 human epitope |
RYPLTFGW
|
Nef(134-141) | A*24:02 human epitope |
RYPLTFGW
|
Nef(134-141) | A*24:02 human epitope |
RYPLTFGW
|
Nef(134-141) | A*24:02 human epitope |
RYPLTFGW
|
Nef(134-141) | A*24:02 human epitope |
RfPLTFGW
|
Nef(134-141) | susceptible form |
RYPLTlGW
|
Nef(134-141) | non-susceptible form |
RYPLcFGW
|
Nef(134-141) | non-susceptible form |
RfPLcFGW
|
Nef(134-141) | non-susceptible form |
RYPLTFGW
|
Nef(134-141) | A*24:02 human epitope |
RfPLTFGW
|
Nef(134-141) | diminished HLA binding or increased off-rate |
RYPLTFGW
|
Nef(134-141) | A*24:02 human epitope |
RYPLTFGW
|
Nef(134-141) | A*24:02 human epitope |
RfPLTFGW
|
Nef(134-141) | observed variant |
RfPiTFGW
|
Nef(134-141) | observed variant |
RYPiTFGW
|
Nef(134-141) | observed variant |
RYPLTFGW
|
Nef(134-141) | A*29 human epitope |
RYPLTFGW
|
Nef(134-141) | A33 human epitope |
RYPLTFGW
|
Nef(134-141) | B*18 human epitope |
RYPLTFGW
|
Nef(134-141) | B*27 human epitope |
RYPLTFGW
|
Nef(134-141) | B27 human epitope |
RYPLTFGW
|
Nef(134-141) | B27 human epitope |
RYPLTFGW
|
Nef(134-141) | B*35:02, B*35:03, B*53:01 human epitope |
RYPLTFGW
|
Nef(134-141) | C*04 human epitope |
RFPLTFGW
|
Nef(134-141) | human epitope |
RyPLTFGW
|
Nef(134-141) | observed variant |
RYPLTFGWCF
|
Nef(134-143) | A*23:01 human epitope |
RYPLTFGWCF
|
Nef(134-143) | A*23:01 human epitope |
RYPLTFGWCF
|
Nef(134-143) | A*23:01, A*24 human epitope |
RfPLTFGWCF
|
Nef(134-143) | altered HLA expression; observed variant |
RYPLTFGWCY
|
Nef(134-143) | A*24 human epitope |
RYPLTFGWCf
|
Nef(134-143) | observed variant |
RYPLTFGWCF
|
Nef(134-143) | A*24 human epitope |
RYPLTFGWCF
|
Nef(134-143) | A*24 human epitope |
RYPLTFGWCy
|
Nef(134-143) | observed variant |
RYPLTFGWCF
|
Nef(134-143) | A*24 human epitope |
RYPLcFGWCF
|
Nef(134-143) | subtype-specific susceptible form |
RYPLTFGWCF
|
Nef(134-143) | A*24 human epitope |
RfPLTFGWCF
|
Nef(134-143) | literature escape; observed variant |
kfPLTFGWCF
|
Nef(134-143) | observed variant |
RYPLTlGWCF
|
Nef(134-143) | inferred escape |
RYPLTFGWCY
|
Nef(134-143) | A*24 human epitope |
RYPLcFGWCY
|
Nef(134-143) | observed variant |
RYPLcFGWCf
|
Nef(134-143) | observed variant |
RfPLcFGWCf
|
Nef(134-143) | observed variant |
R(f)YPLcFGWCf
|
Nef(134-143) | observed variant |
RYPLcF(a)GWCf
|
Nef(134-143) | observed variant |
RYPLTFGWCY
|
Nef(134-143) | A24 human epitope |
RYPLTFGWCF
|
Nef(134-143) | A24 human epitope |
RYPLTFGWCY
|
Nef(134-143) | A24 human epitope |
RYPLTFGWCY
|
Nef(134-143) | A24 human epitope |
RYPLTFGWCY
|
Nef(134-143) | A24, B35 human epitope |
RYPLTFGWCf
|
Nef(134-143) | observed variant |
RfPLTFGWCf
|
Nef(134-143) | observed variant |
RYPLTyGWCf
|
Nef(134-143) | observed variant |
RYPLCFGWCF
|
Nef(134-143) | A*24:02 human epitope |
RYPLtFGWCF
|
Nef(134-143) | subtype-specific susceptible form |
RYPLTFGWCF
|
Nef(134-143) | A*24:02 human epitope |
RFPLTFGWCF
|
Nef(134-143) | literature escape; susceptible form; TCR related mutation |
RYPLTFGWCY
|
Nef(134-143) | A*24:02 human epitope |
RYPLTFGWCF
|
Nef(134-143) | A*24:02 human epitope |
RYPLTFGWCF
|
Nef(134-143) | A*24:02 human epitope |
RYPLTFGWCF
|
Nef(134-143) | A*24:02 human epitope |
RfPLTFGWCF
|
Nef(134-143) | escape documented in this paper; observed variant |
RfPLcFGWCF
|
Nef(134-143) | escape documented in this paper; observed variant |
RlPLTFGWCF
|
Nef(134-143) | observed variant |
RwPLTFGWCF
|
Nef(134-143) | observed variant |
RYPLTFGWCy
|
Nef(134-143) | observed variant |
RYPLTlGWCF
|
Nef(134-143) | observed variant |
RYPLTlGWCy
|
Nef(134-143) | observed variant |
RYPLTFGWpF
|
Nef(134-143) | observed variant |
RYPLcFGWCF
|
Nef(134-143) | observed variant |
RYPLTFGWCF
|
Nef(134-143) | A*24:02 human epitope |
RfPLTFGWCF
|
Nef(134-143) | inferred escape; literature escape; replicative capacity reduced |
RYPiTFGWCF
|
Nef(134-143) | observed variant |
RfPiTFGWCF
|
Nef(134-143) | observed variant |
RfPLcFGWCF
|
Nef(134-143) | observed variant |
RYPLcFGWCF
|
Nef(134-143) | inferred escape; literature escape |
RYPLTFGWCF
|
Nef(134-143) | A*24:02 human epitope |
RfPLTFGWCF
|
Nef(134-143) | diminished HLA binding or increased off-rate |
RYPLTlGWCF
|
Nef(134-143) | observed variant |
RYPLTFGWCy
|
Nef(134-143) | observed variant |
RfPLTFGWCy
|
Nef(134-143) | observed variant |
RYPLTFGWpF
|
Nef(134-143) | observed variant |
RfPLTFGWpF
|
Nef(134-143) | observed variant |
RxPLTFGWpF
|
Nef(134-143) | observed variant |
RYPiTFGWCF
|
Nef(134-143) | observed variant |
RfPmTFGWCF
|
Nef(134-143) | observed variant |
RYPcTFGWCF
|
Nef(134-143) | observed variant |
RfPcTFGWCF
|
Nef(134-143) | observed variant |
RwPLTFGWCF
|
Nef(134-143) | observed variant |
RYPLTFGWCF
|
Nef(134-143) | A*24:02 human epitope |
RYPLTFGWCF
|
Nef(134-143) | A*24:02 human epitope |
RfPLTFGWCF
|
Nef(134-143) | escape documented in this paper |
RYPLTFGWCy
|
Nef(134-143) | observed variant |
RYPLcFGWCF
|
Nef(134-143) | observed variant |
RfPLcFGWCF
|
Nef(134-143) | observed variant |
RfPLlFGWCF
|
Nef(134-143) | observed variant |
RfPiTFGWCF
|
Nef(134-143) | observed variant |
RYPLTFGWpF
|
Nef(134-143) | observed variant |
RlPLTFGWCF
|
Nef(134-143) | observed variant |
RfPLTFGWsF
|
Nef(134-143) | observed variant |
RYPLTFGWCF
|
Nef(134-143) | A*24:02 human epitope |
RYPLTFGWCF
|
Nef(134-143) | A*24:02 human epitope |
RYPLTFGWCF
|
Nef(134-143) | A*24:02 human epitope |
RfPLTFGWCF
|
Nef(134-143) | escape documented in this paper; processing |
RYPLTFGWCF
|
Nef(134-143) | A*24:02 human epitope |
RYPLTFGWCF
|
Nef(134-143) | A*24:02 human epitope |
RYPLcFGWCF
|
Nef(134-143) | subtype-specific susceptible form |
RYPLTFGWCY
|
Nef(134-143) | A*24:02 human epitope |
RfPLTFGWCY
|
Nef(134-143) | escape documented in this paper |
RYPLTFGWCF
|
Nef(134-143) | A*24:02 human epitope |
RfPLTFGWCF
|
Nef(134-143) | observed variant |
RfPiTFGWCF
|
Nef(134-143) | observed variant |
RYPiTFGWCF
|
Nef(134-143) | observed variant |
RYPLTFGWCF
|
Nef(134-143) | A*24:02 human epitope |
RfPLTFGWCF
|
Nef(134-143) | TCR related mutation |
RYPLTFGWCY
|
Nef(134-143) | A*24:02 human epitope |
RYPLTFGWCF
|
Nef(134-143) | B*35 human epitope |
RYPLTFGWCY
|
Nef(134-143) | C*07 human epitope |
RYPLTFGWCY
|
Nef(134-143) | C*07:02 human epitope |
RYPLTFGWCf
|
Nef(134-143) | HLA binding unchanged |
RYPLTFGWC-
|
Nef(134-143) | diminished HLA binding or increased off-rate |
RfPLTFGWCY
|
Nef(134-143) | diminished HLA binding or increased off-rate |
RlPLTFGWCY
|
Nef(134-143) | diminished HLA binding or increased off-rate |
--PLTFGWCf{kl}
|
Nef(134-143) | diminished HLA binding or increased off-rate |
RYPLTFGWCF
|
Nef(134-143) | human epitope |
--PLTFGWCyKL
|
Nef(134-143) | HLA association; susceptible form |
-fPLTFGWCG
|
Nef(134-143) | HLA association; susceptible form |
-YPLTFGWCy
|
Nef(134-143) | HLA association; susceptible form |
{t}RYPLTFGW
|
Nef(134-143) | HLA association; susceptible form |
RYPLTFGWCF
|
Nef(134-143) | human epitope |
RYPLTFGWCF
|
Nef(134-143) | human epitope |
RYPLTFGWCYK
|
Nef(134-144) | B18 human epitope |
RYPLcFGWCYK
|
Nef(134-144) | escape documented in this paper |
RYPLTFGWCYK
|
Nef(134-144) | B18 human epitope |
RYPLTFGWCFKLVPV
|
Nef(134-148) | human epitope |
RYPLTFGWCFKLVPV
|
Nef(134-148) | human epitope |
YPLTFGWCF
|
Nef(135-143) | A2 human epitope |
YPLTFGWCY
|
Nef(135-143) | A*23 human epitope |
YPLTFGWCF
|
Nef(135-143) | A*23 human epitope |
YPLTFGWCF
|
Nef(135-143) | A*24 human epitope |
FPLTFGWCF
|
Nef(135-143) | A*24:02 human epitope |
YPLTFGWCY
|
Nef(135-143) | B*07, B*35 human epitope |
YPLTFGWCY
|
Nef(135-143) | B*07:02 human epitope |
YPLTFGWCY
|
Nef(135-143) | B*07:02 human epitope |
YPLTFGWCF
|
Nef(135-143) | B*07:02, B*18:01 human epitope |
YPLTFGWCY
|
Nef(135-143) | B*18 human epitope |
YPLTFGWCF
|
Nef(135-143) | B*18 human epitope |
YPLTFGWCF
|
Nef(135-143) | B*18 human epitope |
YPLTFGWCF
|
Nef(135-143) | B*18 human epitope |
YPLTFGWCF
|
Nef(135-143) | B*18, B*35 human epitope |
YPLTFGWCY
|
Nef(135-143) | B18 human epitope |
YPLTFGWCY
|
Nef(135-143) | B18 human epitope |
YPLTFGWCY
|
Nef(135-143) | B18 human epitope |
YPLTFGWCF
|
Nef(135-143) | B18 human epitope |
YPLTFGWCY
|
Nef(135-143) | B18 human epitope |
YPLTFGWCY
|
Nef(135-143) | B18 human epitope |
YPLTFGWCY
|
Nef(135-143) | B18 human epitope |
YPLTFGWCY
|
Nef(135-143) | B18 human epitope |
YPLTFGWCF
|
Nef(135-143) | B18 human epitope |
YPLTFGWCF
|
Nef(135-143) | B18, B35 human epitope |
fPLTFGWCF
|
Nef(135-143) | susceptible form; subtype-specific susceptible form |
YPLcFGWCF
|
Nef(135-143) | susceptible form; subtype-specific susceptible form |
fPLcFGWCF
|
Nef(135-143) | susceptible form; subtype-specific susceptible form |
YPLTFGWCy
|
Nef(135-143) | susceptible form; subtype-specific susceptible form |
YPLTlGWCF
|
Nef(135-143) | non-susceptible form; susceptible form; subtype-specific non-susceptible form |
YPLTFGWCY
|
Nef(135-143) | B18, B35, B49, B53, B7 human epitope |
YPLTFGWCf
|
Nef(135-143) | susceptible form |
YPLTFGWCF
|
Nef(135-143) | B*53:01, B18, B35 human epitope |
YPLTFGWCY
|
Nef(135-143) | B18, B49 human epitope |
YPLTFGWCf
|
Nef(135-143) | susceptible form |
YPLTFGWCY
|
Nef(135-143) | B18, B53, B7 human epitope |
YPLTFGWCf
|
Nef(135-143) | observed variant |
fPLTFGWCf
|
Nef(135-143) | observed variant |
YPLTyGWCf
|
Nef(135-143) | observed variant |
YPLTFGWCF
|
Nef(135-143) | B*53:01, B18 human epitope |
YPLTFGWCF
|
Nef(135-143) | B*18:01 human epitope |
YPLTGWCF
|
Nef(135-143) | B*18:01 human epitope |
YPLTFGWCF
|
Nef(135-143) | B*18:01 human epitope |
YPLTFGWCY
|
Nef(135-143) | B*18:01 human epitope |
YPLTFGWCY
|
Nef(135-143) | B*35 human epitope |
YPLTFGWCF
|
Nef(135-143) | B*35 human epitope |
YPLcFGWCF
|
Nef(135-143) | subtype-specific susceptible form |
YPLTFGWCF
|
Nef(135-143) | B*35 human epitope |
YPLTFGWCF
|
Nef(135-143) | B*35 human epitope |
YPLTFGWCF
|
Nef(135-143) | B*35 human epitope |
YPLTFGWCY
|
Nef(135-143) | B*35 human epitope |
fPLTFGWCY
|
Nef(135-143) | observed variant |
YPLTlGWCY
|
Nef(135-143) | escape documented in this paper |
YPLcFGWCY
|
Nef(135-143) | escape documented in this paper |
YPLTFGWCY
|
Nef(135-143) | B*35, B*53:01 human epitope |
YPLTFGWCY
|
Nef(135-143) | B35 human epitope |
YPLTFGWCY
|
Nef(135-143) | B35 human epitope |
YPLTFGWCF
|
Nef(135-143) | B35 human epitope |
YPLTFGWCY
|
Nef(135-143) | B35 human epitope |
YPLTFGWCF
|
Nef(135-143) | B35 human epitope |
YPLTFGWCF
|
Nef(135-143) | B*35:01 human epitope |
fPLTFGWCF
|
Nef(135-143) | observed variant; replicative capacity reduced |
lPLTFGWCF
|
Nef(135-143) | observed variant; replicative capacity is not abrogated; susceptible form |
YPLTFGWCF
|
Nef(135-143) | B*35:01 human epitope |
YPLTFGWCY
|
Nef(135-143) | B*35:01 human epitope |
YPLTFGWCY
|
Nef(135-143) | B*35:01, B*35:08 human epitope |
YPLTFGWCF
|
Nef(135-143) | B*35:01, B*53:01 human epitope |
YPLTFGWCY
|
Nef(135-143) | B*35:02, B*35:03, B*53:01 human epitope |
YPLTFGWCF
|
Nef(135-143) | B*35:02, B*35:03, B*53:01 human epitope |
YPLTFGWCY
|
Nef(135-143) | B49 human epitope |
YPLTFGWCf
|
Nef(135-143) | observed variant |
YLPTFGWCY
|
Nef(135-143) | B49 human epitope |
YLPTFGWCf
|
Nef(135-143) | observed variant |
YPLTFGWCY
|
Nef(135-143) | B49 human epitope |
YPLTFGWCY
|
Nef(135-143) | B49 human epitope |
YPLTFGWCF
|
Nef(135-143) | B*53 human epitope |
YPLTFGWCF
|
Nef(135-143) | B*53 human epitope |
YPLTFGWCY
|
Nef(135-143) | B53 human epitope |
YPLTFGWCF
|
Nef(135-143) | B53 human epitope |
YPLTFGWCF
|
Nef(135-143) | B*53:01 human epitope |
YPLTFGWCF
|
Nef(135-143) | B*53:01 human epitope |
YPLTFGWCY
|
Nef(135-143) | B*53:01 human epitope |
YPLTFGWCY
|
Nef(135-143) | B*53:01 human epitope |
YPLTFGWCF
|
Nef(135-143) | B*57 human epitope |
YPLTFGWCF
|
Nef(135-143) | B*58:01 human epitope |
YPLTFGWCY
|
Nef(135-143) | B7 human epitope |
YPLTFGWCF
|
Nef(135-143) | B7 human epitope |
YPLTFGWCY
|
Nef(135-143) | B7 supertype human epitope |
YPLTFGWCF
|
Nef(135-143) | C*02 human epitope |
YPLTFGWCF
|
Nef(135-143) | C*04 human epitope |
YPLTFGWCY
|
Nef(135-143) | C*07:02 human epitope |
YPLTFGWCY
|
Nef(135-143) | human epitope |
YPLTFGWCF
|
Nef(135-143) | human epitope |
YPLTFGWCFKLVPV
|
Nef(135-148) | human epitope |
YPLTFGWCFKLVPV
|
Nef(135-148) | human epitope |
PLTFGWCYK
|
Nef(136-144) | A3 human epitope |
PLTFGWCYKL
|
Nef(136-145) | A*02 human epitope |
PLcFGWCfKL
|
Nef(136-145) | observed variant |
PLcF(a)GWCfKL
|
Nef(136-145) | observed variant |
PLTFGWCFKL
|
Nef(136-145) | A*02 human epitope |
PLTFGWCYKL
|
Nef(136-145) | A*02 human epitope |
PLcFGWCfKL
|
Nef(136-145) | subtype-specific non-susceptible form |
PLTFGWCYKL
|
Nef(136-145) | A*02 human epitope |
PLTFGWCYKL
|
Nef(136-145) | A*02 human epitope |
PLTFGWCYKL
|
Nef(136-145) | A*02 human epitope |
PLTFGWCYKL
|
Nef(136-145) | A*02 human epitope |
PLTFGWCYKL
|
Nef(136-145) | A*02:01 human epitope |
PLTFGWCYKL
|
Nef(136-145) | A*02:01 human epitope |
PLTFGWCYKL
|
Nef(136-145) | A*02:01 human epitope |
PLTFGWCFKL
|
Nef(136-145) | A*02:01 transgenic mouse epitope |
PLTFGWCYKL
|
Nef(136-145) | A*02:01 human epitope |
PLTFGWCFKL
|
Nef(136-145) | A2 human epitope |
PLTFGWCYKL
|
Nef(136-145) | A2 human epitope |
PLTFGWCYKL
|
Nef(136-145) | A2 human epitope |
PLTFGWCYKL
|
Nef(136-145) | A2 human epitope |
PLTFGWCYKL
|
Nef(136-145) | A2 human epitope |
PLTFGWCYKL
|
Nef(136-145) | A*32 human epitope |
PLTFGWCYKL
|
Nef(136-145) | B*07 human epitope |
PLTFGWCYKL
|
Nef(136-145) | B*18 human epitope |
PLTFGWCYKL
|
Nef(136-145) | B*35:02, B*35:03, B*53:01 human epitope |
PLTFGWCYKL
|
Nef(136-145) | B*49 human epitope |
PLTFGWCYKL
|
Nef(136-145) | B*58:01 human epitope |
PLTFGWCYKL
|
Nef(136-145) | C*14 human epitope |
PLTFGWCFKL
|
Nef(136-145) | human epitope |
PLTFGWCyKL
|
Nef(136-145) | observed variant |
PLTFGWCFKL
|
Nef(136-145) | human epitope |
PLTLGWCFKL
|
Nef(136-145) | observed variant |
PITFGWCFKL
|
Nef(136-145) | susceptible form |
PVTFGWCFKL
|
Nef(136-145) | susceptible form |
PLCFGWCFKL
|
Nef(136-145) | susceptible form |
PVCFGWCFKL
|
Nef(136-145) | observed variant |
PMCFGWCFKL
|
Nef(136-145) | susceptible form |
PLCFGWCFKP
|
Nef(136-145) | susceptible form |
PLTFGWCFKL
|
Nef(136-145) | human epitope |
PLTFGWCYKLV
|
Nef(136-146) | A*02:01 human epitope |
LTFGWCFKL
|
Nef(137-145) | A*02 human epitope |
LTFGWCFKL
|
Nef(137-145) | A*02:01 human epitope |
LTFGWCFKL
|
Nef(137-145) | A*02:01 mouse epitope |
LTFGWCFKL
|
Nef(137-145) | A*02:01 human epitope |
LTFGWCFKL
|
Nef(137-145) | A*02:01 human epitope |
LTFGWCYKL
|
Nef(137-145) | A2 human epitope |
LTFGWCFKL
|
Nef(137-145) | A2 human epitope |
LTFGWCFKL
|
Nef(137-145) | A2 human epitope |
LTFGWCFKL
|
Nef(137-145) | A2 human epitope |
LTFGWCFKL
|
Nef(137-145) | A2 human epitope |
LTFGWCFKL
|
Nef(137-145) | A*23 human epitope |
LTFGWCFKL
|
Nef(137-145) | A*25 human epitope |
LTFGWCFKL
|
Nef(137-145) | A2 supertype human epitope |
LTFGWCFKL
|
Nef(137-145) | A2 supertype human, mouse epitope |
LTFGWCFKL
|
Nef(137-145) | A*32 human epitope |
LTFGWCFKL
|
Nef(137-145) | A*68:02 human epitope |
LTFGWCFKL
|
Nef(137-145) | A*80 human epitope |
LTFGWCFKL
|
Nef(137-145) | B*15:17, B57 human epitope |
LTFGWCFKL
|
Nef(137-145) | B*15:40 human epitope |
LTFGWCFKL
|
Nef(137-145) | B*57 human epitope |
LTFGWCFKL
|
Nef(137-145) | B*57 human epitope |
LTFGWCFKL
|
Nef(137-145) | B*63 human epitope |
LTFGWCFKL
|
Nef(137-145) | C*14 human epitope |
LTFGWCFKL
|
Nef(137-145) | human epitope |
LTFGWCFKL
|
Nef(137-145) | human epitope |
LTFGWCFKL
|
Nef(137-145) | human epitope |
LTFGWCFKLV
|
Nef(137-146) | A2 human epitope |
LTFGWCFKLV
|
Nef(137-146) | A2 human epitope |
LTFGWCFKLV
|
Nef(137-146) | A2 human epitope |
LTFGWCFKLV
|
Nef(137-146) | A2 human epitope |
LTFGWCFKLV
|
Nef(137-146) | A2 human epitope |
LTFGWCFKLV
|
Nef(137-146) | A2 human epitope |
LTFGWCFKLV
|
Nef(137-146) | A*23 human epitope |
LTFGWCFKLV
|
Nef(137-146) | A2 supertype human epitope |
LTFGWCFKLV
|
Nef(137-146) | A*32 human epitope |
LTFGWCFKLV
|
Nef(137-146) | A*68:02 human epitope |
LTFGWCFKLV
|
Nef(137-146) | A*80 human epitope |
LTFGWCFKLV
|
Nef(137-146) | B*15:17 human epitope |
LTFGWCYKLV
|
Nef(137-146) | human epitope |
LTFGWCFKLVPVEPEKVE
|
Nef(137-154) | human epitope |
WCFKLVPV
|
Nef(141-148) | A2 human, transgenic mouse epitope |
WCFKLVPV
|
Nef(141-148) | A2 human epitope |
WCyKLVPV
|
Nef(141-148) | observed variant |
WCFKLVPV
|
Nef(141-148) | A2 human epitope |
CYKLVPVEPDKVEEANKGEN
|
Nef(142-161) | human epitope |
FKLVPVDPEEVEEAN
|
Nef(143-157) | human epitope |